Central Retinal Artery Occlusion clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • KUS121 in Participants With Acute Non-Arteritic Central Retinal Artery Occlusion (CRAO)

    open to eligible people ages 20 years and up

    Central retinal artery occlusion (CRAO) is an ophthalmologic emergency which leads to severe and permanent vision loss. There is no evidence-based therapy for CRAO. The objective of this GION study is to evaluate the efficacy and safety of KUS121 intravitreal (IVT) injection in participants with acute non-arteritic CRAO.

    at UCSD

Our lead scientists for Central Retinal Artery Occlusion research studies include .

Last updated: